Thermal Ablation Followed by Immunotherapy for HCC

NCT03864211 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

145

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma Non-resectable

Interventions

PROCEDURE: Thermal ablation
DRUG: Toripalimab

Sponsor

Xiangya Hospital of Central South University